Massimo Cristofanilli

25PUBLICATIONS
235CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targetsTumour immunologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Carolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana

|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Aug 25, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Lorenzo Gerratana, Carolina Reduzzi, Yue Ren

|Aug 14, 2025
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.

Andrew A Davis, Ellen Jaeger, Ian S Hagemann

|Jun 02, 2025
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.

François-Clément Bidard, Erica L Mayer, Yeon Hee Park

Pageof 5